π Eloralinitide: Amylin, with and without GLP1
Weight loss, no matter how you take this new peptide
One trend that has firmly taken hold at pharmaceuticals that produce GLP1 Receptor Agonists is the introduction of an Amylin hormone analog to βboostβ the effects of existing GLP1s.
What does Amlyin do and why does it make a great complement to GLP1s? We take a look at some early data (ahead of Eli Lillyβs big update) and explain a bit about how these new drugs work.